Latest oppositions filed by Ammelburg, Moritz

This table presents recent patent oppositions filed by Ammelburg, Moritz against its competitors. It outlines key details of each case, including the patent title, filing date and the applicant. This information provides insights into the competitive landscape and highlights active disputes over patent grant within the industry.

Patent NumberTitleApplicantOpposition Date
EP3400947Modulation Of Apolipoprotein C-Iii (Apociii) Expression In Lipoprotein Lipase Deficient (Lpld) PopulationsIONIS PHARMACEUTICALS, INC.May 22, 2024
EP3607069Products And CompositionsSILENCE THERAPEUTICS GMBHJul 31, 2023
EP3895712Engineered Natural Killer Cells And Uses ThereofONK THERAPEUTICS LIMITEDMar 21, 2023
EP3213085Biomarkers For Risk Prediction Of MortalityF. HOFFMANN-LA ROCHE AGSep 12, 2019
EP3016654Tauroursodeoxycholic Acid (Tudca) For Use In The Treatment Of Neurodegenerative DisordersBRUSCHETTINI S.R.L.Jun 4, 2019